Ionis Pharmaceuticals, Inc.
IONS
$34.30
$1.344.07%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.92% | 12.37% | -18.35% | -16.99% | -35.80% |
| Total Depreciation and Amortization | -2.26% | -6.61% | -4.21% | -1.20% | 1.78% |
| Total Amortization of Deferred Charges | 5.69% | 11.26% | 18.60% | 18.04% | 17.81% |
| Total Other Non-Cash Items | 24.68% | 382.77% | 345.32% | 407.86% | 370.06% |
| Change in Net Operating Assets | -171.02% | -11.47% | -2.76% | -55.19% | -1,120.47% |
| Cash from Operations | -62.90% | 34.89% | 24.12% | 14.14% | -12.08% |
| Capital Expenditure | -90.21% | 34.07% | 62.54% | 24.11% | -51.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.37% | -492.53% | 198.39% | 174.10% | 22.92% |
| Cash from Investing | 37.41% | -1,025.70% | 179.22% | 162.39% | 18.47% |
| Total Debt Issued | -- | -100.00% | -100.00% | -- | -- |
| Total Debt Repaid | 90.85% | 99.97% | 85.57% | -862.25% | -862.99% |
| Issuance of Common Stock | 957.26% | 6,140.30% | 799.34% | 894.93% | 675.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -93.31% | -96.29% | 1,750,937.93% |
| Cash from Financing | -25.78% | 1.91% | -94.10% | -60.47% | 1,264.81% |
| Foreign Exchange rate Adjustments | -177.56% | -4.40% | -87.23% | 183.75% | 184.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -228.01% | -147.09% | -34.67% | 117.07% | 120.72% |
